Literature DB >> 7437205

Extreme tachycardia complicating the use of disopyramide in atrial flutter.

C E Robertson, H C Miller.   

Abstract

A 59-year-old man presented with atrial flutter and a 2:1 atrioventricular response, which, after intravenous disopyramide, became 1:1. A mechanism of slowed atrial flutter rate and improved atrioventricular nodal conduction, similar to that recognised with quinidine, is suggested.

Entities:  

Mesh：

Substances：

Year:  1980        PMID： 7437205      PMCID： PMC482452          DOI： 10.1136/hrt.44.5.602

Source DB:  PubMed          Journal:  Br Heart J        ISSN： 0007-0769


  4 in total

1.  Electrophysiological evaluation of disopyramide in man.

Authors:  M E Josephson; A R Caracta; S H Lau; J J Gallagher; A N Damato
Journal:  Am Heart J       Date:  1973-12       Impact factor: 4.749

2.  Atypical ventricular tachycardia as a manifestation of disopyramide toxicity.

Authors:  R S Meltzer; E W Robert; M McMorrow; R P Martin
Journal:  Am J Cardiol       Date:  1978-12       Impact factor: 2.778

3.  Electrophysiologic effects of the antiarrhythmic agent disopyramide phosphate.

Authors:  B Befeler; A Castellanos; D E Wells; M C Vagueiro; B K Yeh
Journal:  Am J Cardiol       Date:  1975-02       Impact factor: 2.778

Review 4.  Disopyramide: a review of its pharmacological properties and therapeutic use in treating cardiac arrhythmias.

Authors:  R C Heel; R N Brogden; T M Speight; G S Avery
Journal:  Drugs       Date:  1978-05       Impact factor: 9.546
  4 in total
  3 in total

1.  Propafenone versus disopyramide for maintenance of sinus rhythm after electrical cardioversion of chronic atrial fibrillation: a randomized, double-blind study. PRODIS Study Group.

Authors:  H J Crijns; A T Gosselink; K I Lie
Journal:  Cardiovasc Drugs Ther       Date:  1996-05       Impact factor: 3.727

2.  Intravenous cibenzoline in the management of acute supraventricular tachyarrhythmias.

Authors:  P Bru; R Cointe; F Paganelli; P Ricard; S Lévy
Journal:  Cardiovasc Drugs Ther       Date:  1995-02       Impact factor: 3.727

Review 3.  Pharmacological management of arrhythmias in the elderly.

Authors:  I C Van Gelder; J Brügemann; H J Crijns
Journal:  Drugs Aging       Date:  1997-08       Impact factor: 4.271
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.